Relay to Host the 'SBOMs Impact on Critical Infrastructure' for the Fourth Live Webinar on the State of Cybersecurity Industry

Toronto, Ontario--(Newsfile Corp. - November 19, 2021) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company") is pleased to host the fourth episode of "State of Cybersecurity Industry: SBOMs Impact on Critical Infrastructure"1 on November 30th at 1pm EST, and featuring renowned industry leaders in the cybersecurity sector.

The industry panelists include Allan Friedman2, Senior advisor and Strategist at Cybersecurity and Infrastructure Security Agency (CISA), Ginger Wright3, Energy Cyber Portfolio Manager at Idaho National Labs and Tim Roxey4, President at Eclectic Technology. The panel will be moderated by Chuck Brooks5, respected influencer and Forbes writer.

"SBOM can be utilized for risk management and assessment while providing transparency into the ingredients of traditional software, web services and devices. Its value goes beyond that - for management and operations of any components in the digital inventory," said Chuck Brooks.

Register for the 'SBOMs Impact on Critical Infrastructure' Free Webinar using the link below:

Cannot view this image? Visit:

Fourth Live Webinar Event

To view an enhanced version of this graphic, please visit:

Software Bills of Materials (SBOMs) are beginning to arrive at critical infrastructure operators' doors. The promises of much more rapid responses and awareness to cybersecurity vulnerabilities and other tangible benefits are waiting in the wings to be proven or disproven. What will the impact of this new form of visibility and information sharing actually be?

As leaders in SBOMs, these panelists will discuss how those in the critical infrastructure industry can better create and utilize SBOMs. The event will be hosted live on the Cybeats YouTube6 channel on November 30th at 1pm EST. Panelists will discuss the increasing demand for SBOMs and the greater importance of the longevity and credibility of software, ultimately showcasing how it offers a vital solution.

RECENT NEWS: Cybeats was recently highlighted in a Forbes Article:

SUBSCRIBE: For more information on Relay or to subscribe to the Company's mailing list visit:

About Relay Medical Corp.
Relay Medical is a technology innovator headquartered in Toronto, Canada focused on the development of novel solutions in the diagnostics, AI data science and IoT security sectors.


Destine Lee
Media & Communications
Relay Medical Corp.
Office. 647-872-9982
TF. 1-844-247-6633
Media Inquiries:
Investor Relations:

Forward-looking Information Cautionary Statement
Except for statements of historic fact, this news release contains certain "forward-looking information" within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements are based on the opinions and estimates at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements including, but not limited to delays or uncertainties with regulatory approvals, including that of the CSE. There are uncertainties inherent in forward-looking information, including factors beyond the Company's control. There are no assurances that the commercialization plans for the technology described in this news release will come into effect on the terms or time frame described herein. The Company undertakes no obligation to update forward-looking information if circumstances or management's estimates or opinions should change except as required by law. The reader is cautioned not to place undue reliance on forward-looking statements. Additional information identifying risks and uncertainties that could affect financial results is contained in the Company's filings with Canadian securities regulators, which filings are available at


Cannot view this image? Visit:

To view the source version of this press release, please visit